4.2 Review

Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers

Related references

Note: Only part of the references are listed.
Letter Medical Laboratory Technology

Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients

Kamon Shirakawa et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)

Review Infectious Diseases

Biomarkers for pediatric sepsis and septic shock

Stephen W. Standage et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)

Review Critical Care Medicine

Biomarker discovery and development in pediatric critical care medicine

Jennifer M. Kaplan et al.

PEDIATRIC CRITICAL CARE MEDICINE (2011)

Article Obstetrics & Gynecology

Reliability of procalcitonin in neonatology. Experience in 59 preterm newborns

Serena Spada et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2009)

Article Microbiology

Structural biology of the LPS recognition

Roman Jerala

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)

Review Immunology

The role of lipopolysaccharide-binding protein in modulating the innate immune response

Janine Zweigner et al.

MICROBES AND INFECTION (2006)

Article Immunology

CD14 is an acute-phase protein

S Bas et al.

JOURNAL OF IMMUNOLOGY (2004)

Review Biochemistry & Molecular Biology

Novel strategies for the treatment of sepsis

NC Riedemann et al.

NATURE MEDICINE (2003)